| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.21B | -27.4% |
| Cost of Revenue | $2.63B | -27.8% |
| Gross Profit | $1.58B | -26.6% |
| R&D Expense | $316.2M | -31.2% |
| SG&A Expense | $755.5M | -13.5% |
| Operating Income | $256.5M | +327.2% |
| Interest Expense | $686.9M | +1.6% |
| Pre-tax Income | -$409.3M | +43.0% |
| Income Tax | $51.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $564.9M | +3.9% |
| Accounts Receivable | $685.9M | -15.9% |
| Inventory | $736.8M | -31.8% |
| Current Assets | $3.48B | +21.7% |
| Total Assets | $8.75B | -6.7% |
| Current Liabilities | $1.23B | -12.8% |
| Long-term Debt | $9.24B | -0.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $273.1M | -5.8% |
| Capital Expenditures | $25.3M | -52.5% |
| Investing Cash Flow | -$57.2M | -249.3% |
| Financing Cash Flow | -$83.0M | +54.3% |
| Free Cash Flow | $247.8M | +4.7% |
| -61.2% |
| Net Income | -$315.5M | +78.3% |
| EPS (Basic) | -$1.78 | +75.2% |
| EPS (Diluted) | -$1.78 | +75.2% |
| Total Liabilities |
| $10.98B |
| -1.8% |
| Stockholders' Equity | -$3.46B | -16.4% |